Ignite Creation Date:
2025-12-25 @ 1:17 AM
Ignite Modification Date:
2026-02-13 @ 8:05 AM
Study NCT ID:
NCT03920293
Status:
COMPLETED
Last Update Posted:
2024-05-28
First Post:
2019-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-12
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-25
Completion Date Type:
ACTUAL
First Submit Date:
2019-04-16
First Submit QC Date:
None
Study First Post Date:
2019-04-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-05-03
Results First Submit QC Date:
None
Results First Post Date:
2022-05-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2022-03-15
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-04-26
Last Update Post Date:
2024-05-28
Last Update Post Date Type:
ACTUAL